Read + Share
Amedeo Smart
Independent Medical Education
Odia Y, Hall MD, Cloughesy TF, Wen PY, et al. Selective DRD2 Antagonist and ClpP Agonist ONC201 in a Recurrent Non-midline H3 K27M-mutant Glioma Cohort. Neuro Oncol 2024 Feb 22:noae021. doi: 10.1093.PMID: 38386699
Email
LinkedIn
Facebook
Twitter
Privacy Policy